BENCHMARK HOLDINGS PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 44.1 GBX | +1.38% |
|
+2.80% | +29.52% |
| Feb. 15 | Benchmark Holdings swings to quarterly loss, but optimistic | AN |
| Feb. 15 | Transcript : Benchmark Holdings plc, Q1 2024 Earnings Call, Feb 15, 2024 |
Presenter SpeechTrond Williksen (Executives)Good morning to all of you, and welcome to our Hal...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Benchmark Holdings plc is a United Kingdom-based aquaculture biotechnology company. The Company is focused on providing specialized mission-critical solutions in three complementary areas: genetics, health and advanced nutrition. The Companyâs segments include Genetics, Advanced Nutrition and Health. The Genetics segment is salmon breeding technology combined with production facilities to provide a range of genetic merit ova. The Advanced Nutrition segment manufactures and provides nutrition and health products to the global aquaculture industry. The Health segment is focused on providing health products to the global aquaculture market. The Company has a portfolio of products and solutions, including salmon eggs with specialist genetic traits, shrimp broodstock, tilapia fry, technology enhanced live feed (Artemia), specialist diets, probiotics, and sea lice treatment solutions.
Sector
Fishing & Farming
Calendar
2024-05-14
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
0.441
GBP
Average target price
0.5758
GBP
Spread / Average Target
+30.57%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +29.52% | 402M | |
| +21.24% | 3.46B | |
| 0.00% | 1.03B | |
| -.--% | 479M | |
| +1.94% | 418M | |
| -4.14% | 390M | |
| -20.17% | 383M | |
| +21.27% | 356M | |
| +18.85% | 343M | |
| +2.65% | 261M |
- Stock Market
- Equities
- BMK Stock
- News Benchmark Holdings plc
- Transcript : Benchmark Holdings plc, Q2 2022 Earnings Call, May 18, 2022
